QGEN: Rounding Bottom detected on 16 Nov 2026

All prices, scores, and news on this page reflect data available before market open on .

Free example: 1 of 45 setups from the 16 Nov 2026 scan. Subscribers get the full list every trading day by 6 AM ET.

On 16 Nov 2026, our scan flagged QGEN as a rounding bottom setup scoring 69 out of 98 (Moderate tier), with a 64% win probability based on our historical pattern database and a 5.73 to 1 risk to reward profile from the published levels. This is a swing trade setup: win probability reflects a multi-day swing hold, not an intraday move. At $49.89, the conservative target is $52.81 with a stop at $49.38.

69 of 98
Moderate
64%
Moderate
5.73 : 1
$2.92 to target $0.51 to stop
Swing Trading Plan
Entry
$49.89
$52.81
$49.38
1-6 trading days
Exp. Reward
+$1.56
Exp. Risk
-$0.47

Expected figures are probability-weighted from our historical pattern database; Trade R:R is measured from the entry, target and stop levels.

Current Setup
QGEN is forming a rounding bottom pattern with moderate technical quality (69.0 overall score). The stock has built a support floor around $32.24 and is currently testing resistance near $48.39, trading at $49.89. Structure score of 13.0 and breakout score of 13.0 indicate a well-defined reversal pattern, though volume confirmation remains weak at 0.24x average (9.0 volume score). The setup suggests early-stage accumulation with RSI at 60.61 (neutral territory) and price positioned 54.75% above its 52-week low, indicating recovery momentum without overbought conditions.
Stock Context
QGEN operates in a bullish health care sector (regime score 0.89) amid rising demand for molecular diagnostics and life sciences tools. The stock has gained 17.11% over three months and 8.06% in the past month, outperforming a period of sector strength driven by increased adoption of genomic testing and laboratory automation. A prior flat base pattern (Aug 20, 60 days, weak 25.53 score) transitioned into an ascending triangle (Sep 25, 35 days, weak 25.73 score), suggesting multiple consolidation phases before the current rounding bottom. This pattern stacking indicates institutional accumulation after price pressure, typical of biotech stocks rebuilding confidence following correction phases. The low beta of 0.58 suggests QGEN trades defensively relative to broader market moves.
What to Expect
A successful breakout above $48.39 resistance would target $52.81 conservatively (conservative target) based on measured move projection, representing approximately 6% upside from current levels. Volume confirmation will be critical—breakout strength depends on daily volume expanding well above the 6.7M average (currently 1.64M). Historical rounding bottom patterns show 64.36% win probability at this structure quality. Invalidation occurs at the key support level of $32.24; a close below this level would eliminate the pattern setup and signal a failed recovery. Until price decisively clears and holds above $48.39 on elevated volume, the pattern remains unconfirmed.
Risk Factors
Volume remains a significant weakness—at only 0.24x average, current trading activity is insufficient to validate breakout conviction (9.0 volume score). MACD histogram is negative (-0.2217), suggesting weakening momentum despite price strength, a divergence warning. Biotechnology sector remains subject to regulatory risks around diagnostic claims, reimbursement pressures, and FDA guidance changes that could impact QGEN's product portfolio. With earnings cycles often driving sharp biotech moves, an unfavorable earnings miss or guidance cut could collapse the pattern below $32.24 support. The 12.93% gap below 52-week highs indicates prior resistance that could cap near-term upside. Low volatility (ATR 0.32, 0.64%) provides limited cushion for stop losses near support.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading. What the terms mean →
Frequently Asked Questions
Is QGEN a good swing trade?
QGEN scored 69 out of 98 on our rounding bottom scan, with a 64% historical win probability over a 1-6 trading days hold. Moderate setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $49.89, with a conservative target of $52.81 and a stop loss at $49.38.
What would invalidate this rounding bottom setup?
A close below the stop loss at $49.38 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical rounding bottom setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bullish 0.89
-1.0 0 +1.0
Health Care Sector
Bullish 0.89
-1.0 0 +1.0
Other Patterns Detected Today
Flat Base
60 days in pattern
Weak 25.5
Ascending Triangle
35 days in pattern
Weak 25.7
Overall Score
35 of 40
Strong
Pattern Quality
9 of 20
Weak
Setup
15 of 20
Good
R/R
10 of 18
Fair
Context
Pattern Quality Score
13 of 15
Strong
Structure
13 of 13
Exceptional
Breakout
9 of 12
Good
Volume
Recent Performance
-0.9%
1W
-0.7%
2W
+8.1%
1M
+17.1%
3M
Momentum & Trend
RSI (14)
60.6
Neutral
MACD Histogram
-0.22
Bearish
Bollinger Band Position
44.9%
Mid Zone
Volatility & Risk
20-Day Volatility
0.20
Moderate
ATR %
0.6%
Low
Beta
0.58
Below Mkt
Volume Analysis
Volume Ratio
0.24x
Below Avg
20-Day Avg Vol
6.7M
shares / day
Current Volume
1.6M
shares traded
Price Levels
52W High
$57.30
Target
$52.81
Current
$49.89
Stop Loss
$49.38
Resistance
$48.39
Support
$32.24
52W Low
$32.24
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.